212 related articles for article (PubMed ID: 12376107)
21. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
Reinhard C; Shamoon B; Shyamala V; Williams LT
EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
[TBL] [Abstract][Full Text] [Related]
22. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
23. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
[TBL] [Abstract][Full Text] [Related]
24. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
25. Apparently normal tumor necrosis factor receptor 1 signaling in the absence of the silencer of death domains.
Endres R; Häcker G; Brosch I; Pfeffer K
Mol Cell Biol; 2003 Sep; 23(18):6609-17. PubMed ID: 12944486
[TBL] [Abstract][Full Text] [Related]
26. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway.
Chen AJ; Zhou G; Juan T; Colicos SM; Cannon JP; Cabriera-Hansen M; Meyer CF; Jurecic R; Copeland NG; Gilbert DJ; Jenkins NA; Fletcher F; Tan TH; Belmont JW
J Biol Chem; 2002 Sep; 277(39):36592-601. PubMed ID: 12138158
[TBL] [Abstract][Full Text] [Related]
27. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
28. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
29. Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappaB signaling.
Littlejohn AF; Tucker SJ; Mohamed AA; McKay S; Helms MJ; Vandenabeele P; MacEwan DJ
Biochem Pharmacol; 2003 Jan; 65(1):91-9. PubMed ID: 12473383
[TBL] [Abstract][Full Text] [Related]
30. SEK1/MKK4, c-Jun and NFKappaB are differentially activated in forebrain neurons during postnatal development and injury in both control and p75NGFR-deficient mice.
Ward NL; Hagg T
Eur J Neurosci; 2000 Jun; 12(6):1867-81. PubMed ID: 10886328
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of the hepatic mitogen-activated protein kinase and Jun-NH2-terminal kinase pathways in the late-gestation fetal rat.
Boylan JM; Gruppuso PA
Cell Growth Differ; 1996 Sep; 7(9):1261-9. PubMed ID: 8877106
[TBL] [Abstract][Full Text] [Related]
32. Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages.
Mukhopadhyay A; Suttles J; Stout RD; Aggarwal BB
J Biol Chem; 2001 Aug; 276(34):31906-12. PubMed ID: 11438547
[TBL] [Abstract][Full Text] [Related]
33. Impaired TCR-mediated apoptosis and Bcl-XL expression in T cells lacking the stress kinase activator SEK1/MKK4.
Nishina H; Radvanyi L; Raju K; Sasaki T; Kozieradzki I; Penninger JM
J Immunol; 1998 Oct; 161(7):3416-20. PubMed ID: 9759859
[TBL] [Abstract][Full Text] [Related]
34. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
35. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
Hofmann TG; Stollberg N; Schmitz ML; Will H
Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
[TBL] [Abstract][Full Text] [Related]
36. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
37. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.
Mikula M; Schreiber M; Husak Z; Kucerova L; Rüth J; Wieser R; Zatloukal K; Beug H; Wagner EF; Baccarini M
EMBO J; 2001 Apr; 20(8):1952-62. PubMed ID: 11296228
[TBL] [Abstract][Full Text] [Related]
38. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
39. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development.
Swat W; Fujikawa K; Ganiatsas S; Yang D; Xavier RJ; Harris NL; Davidson L; Ferrini R; Davis RJ; Labow MA; Flavell RA; Zon LI; Alt FW
Immunity; 1998 May; 8(5):625-34. PubMed ID: 9620683
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway.
Kuroki DW; Minden A; Sánchez I; Wattenberg EV
J Biol Chem; 1997 Sep; 272(38):23905-11. PubMed ID: 9295340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
